686-50-0
686-50-0
Chemical Structure
H-Leu-Gly-OH
Synonym(s): L-Leucylglycine; Leu-Gly
- CAS No.: 686-50-0
- Formula:C8H16N2O3
- Molecular Weight:188.22
IUPAC Name: L-leucylglycine
InChIKey: LESXFEZIFXFIQR-LURJTMIESA-N
SMILES: O=C(CNC([C@H](CC(C)C)N)=O)O
Biological Activity: H-Leu-Gly-OH is a Glycine (HY-Y0966) derivative[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
H-Leu-Gly-OH | 98.0% | H-Leu-Gly-OH is a Glycine (HY-Y0966) derivative. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Leucyl-L-alanine (Standard) | ≥98% | L-Leucyl-L-alanine (Standard) is the analytical standard of L-Leucyl-L-alanine (HY-128434). This product is intended for research and analytical applications. L-Leucyl-L-alanine is a simple aliphatic dipeptide composed of L-leucine and L-alanine. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
H-Leu-Ser-OH | H-Leu-Ser-OH is a dipeptide formed from L-leucine and L-serine residues and is a metabolite. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Serylleucine | 99.09% | Serylleucine (H-Ser-Leu-OH) is a dipeptide. Serylleucine's core 1 o-glycosylated peptide (SLC1G) can be detected in urine as a metabolite and is a biomarker in TB studies. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
H-Thr-Gly-OH | H-Thr-Gly-OH is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ala-Gly | 98.0% | Ala-Gly is a Glycine (HY-Y0966) derivative. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DL-Alanyl-DL-leucine | 98.0% | DL-Alanyl-DL-leucine is a dipeptide compound composed of alanine and leucine. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
N-Isovaleroylglycine | 99.86% | N-Isovaleroylglycine is a peptidylglycine α-amidating monooxygenase (PAM) inhibitor with a Ki value of 2.0 mM against human hsPAM. N-Isovaleroylglycine undergoes oxidative cleavage by purified rat PAM to produce fatty acid amide and glyoxylic acid. N-Isovaleroylglycine exerts competitive inhibition by binding to hsPAM, blocking the amidation of dansyl-Tyr-Val-Gly. N-Isovaleroylglycine exhibits lowered urinary abundance in MRSA-infected mice, which qualifies it as a non-invasive biomarker. N-Isovaleroylglycine can be used in studies related to Staphylococcus aureus pneumonia and diabetic foot. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Alanyl-L-leucine | 98.0% | L-Alanyl-L-leucine is a competitive inhibitor of small intestinal glycyl-L-leucine hydrolase with Ki values of 0.53 mM (phosphate buffer) or 0.22 mM (Tris buffer). L-Alanyl-L-leucine can be used for research on Hartnup disease and cystinuria. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Isoleucylglycine | L-Isoleucylglycine is a Glycine (HY-Y0966) derivative. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
N-Isobutyrylglycine | 95.0% | N-Isobutyrylglycine is a Glycine (HY-Y0966) derivative. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
